Oncologic resection for malignant tumors of the liver

Annals of Surgery

Volumn 253, Issue 4, 2011, Pages 656-665

  Agrawal, Shefali ^a   Belghiti, Jacques ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; BLOOD TRANSFUSION; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; HUMAN; INTRAOPERATIVE PERIOD; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MORBIDITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; SURGICAL TECHNIQUE; TUMOR VOLUME;

DISEASE-FREE SURVIVAL; EVIDENCE-BASED MEDICINE; FEMALE; HEMOSTASIS, SURGICAL; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPH NODE EXCISION; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79953217340     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181fc08ca     Document Type: Review

References (170)

1. Eguchi S, Kanematsu T, Arii S, et al. Liver Cancer Study Group of Japan. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery. 2008;143:469-475. (Pubitemid 351406380)
2. Are C, Gonen M, Zazzali K, et al. The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg. 2007;246:295-300. (Pubitemid 47196528)
3. Liu CL, Fan ST, Cheung ST, et al. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg. 2006;244:194-203. (Pubitemid 44305533)
4. Zakaria S, Donohue JH, Que FG, et al. Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg. 2007;246:183-191. (Pubitemid 47196514)
5. Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238:720-727. (Pubitemid 38182264)
6. Laurent C, Sa Cunha A, Couderc P, et al. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg. 2003;90:1131-1136. (Pubitemid 37152173)
7. Belghiti J, Ogata S. Preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma. HPB. 2005;7:252-253. (Pubitemid 43878469)
8. Fan ST. Liver functional reserve estimation: state of the art and relevance for local treatments: The Eastern perspective. J Hepatobiliary Pancreat Surg Sci. 2010;17:380-384.
9. Manizate F, Hiotis SP, Labow D, et al. Liver functional resection estimation: state of the art and relevance for local treatments: the Western perspective. J Hepatobiliary Pancreat Surg Sci. 2010;17:385-388.
10. Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009;250:540-548.
11. Schindl MJ, Redhead DN, Fearon KC, et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut. 2005;54:289-296. (Pubitemid 40139248)
12. Torzilli G, Procopio F, CiminoM, et al. Anatomical segmental and subsegmental resection of the liver for hepatocellular carcinoma :a newapproach by means of ultrasound-guided vessel compression. Ann Surg. 2010;251:229-235.
13. Hasegawa K, Kokudo N, Imamura H, et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg. 2005;242:252-259. (Pubitemid 41033442)
14. Vauthey JN, Klimstra D, Franceschi D, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg. 1995;169:28-34.
15. Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg. 1996;83:1219-1222. (Pubitemid 26290448)
16. Kobayashi A, Miyagawa S, Miwa S, et al. Prognostic impact of anatomical resection on early and late intrahepatic recurrence in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2008;15:515-521.
17. Ueno S,Kubo F, Sakoda M, et al. Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classifi- cation. J Hepatobiliary Pancreat Surg. 2008;15:493-500.
18. Regimbeau JM, Kianmanesh R, Farges O, et al. Extent of liver resection in- fluences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery. 2002;131:311-317. (Pubitemid 34229784)
19. Yamamoto M, Takasaki K, Ohtsubo T, et al. Effectiveness of systematized hepatectomywith Glisson's pedicle transection at the hepatic hilus for small nodular hepatocellular carcinoma: retrospective analysis. Surgery. 2001;130:443-448. (Pubitemid 32868456)
20. Tanaka K, Shimada H, Matsumoto C, et al. Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma. Surgery. 2008; 143:607-615. (Pubitemid 351626114)
21. Cho YB, Lee KU, Lee HW, et al. Anatomic versus non-anatomic resection for small single hepatocellular carcinomas. Hepatogastroenterology. 2007;54:1766-1769.
22. Wakai T, Shirai Y, Sakata J, et al. Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol. 2007;14:1356-1365. (Pubitemid 46536830)
23. Ueno S, Sakoda M, Kubo F, et al. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg. 2009;16:359-366.
24. Roayaie S, Blume IN, Thung SN, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137:850-855.
25. Kaibori M, Matsui Y, Hijikawa T, et al. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery. 2006;139:385-394.
26. Yamashita Y, Taketomi A, Itoh S, et al. Long-term favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg. 2007;205:19-26. (Pubitemid 47016949)
27. Ogata S, Belghiti J, FargesO, et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg. 2006;93:1091-1098. (Pubitemid 44343506)
28. Takayama T, Makuuchi M. Preoperative portal vein embolization: is it useful? J Hepatobiliary Pancreat Surg. 2004;11:17-20. (Pubitemid 38404327)
29. Choi JY,Kim MJ, Lee JM, et al. Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography. Am J Roentgenol. 2008;191:1448-1457.
30. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507-517.
31. Burke EC, Jarnagin WR, Hochwald SN, et al. Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg. 1998;228:385-394. (Pubitemid 30191701)
32. Ito F, Agni R, Rettammel RJ, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg. 2008;248:273-279.
33. Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999;230:663-671. (Pubitemid 30191828)
34. Nagino M, Kamiya J, Arai T, et al. "Anatomic" right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma. Ann Surg. 2006;243:28-32. (Pubitemid 43054051)
35. Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg. 2004;240:95-101. (Pubitemid 38808240)
36. Konstadoulakis MM, Roayaie S, Gomatos IP, et al. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg. 2008;196:160-169. (Pubitemid 351970509)
37. Ikeyama T, Nagino M, Oda K, et al. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg. 2007;246:1052-1057. (Pubitemid 350179199)
38. Jarnagin WR, Bowne W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg. 2005;241:703-712.
39. Nimura Y, Hayakawa N, Kamiya J, et al. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14:535-544.
40. Miyazaki M, Kimura F, Shimizu H, et al. One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Surg Sci. 2010;17: 470-475.
41. Neuhaus P, Thelen A. Radical surgery for right-sided klatskin tumor. HPB (Oxford). 2008;10:171-173. (Pubitemid 352016242)
42. Neuhaus P, Jonas S, Settmacher U, et al. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg. 2003;388:194-200. (Pubitemid 36987711)
43. Nagino M, Nimura Y, Nishio H, et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg. 2010;252:115-123.
44. Nagino M, Nimura Y, Kamiya J, et al. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery. 1995;117:677-681.
45. Igami T,NishioH, Ebata T et al. Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience. J Hepatobiliary Pancreat Surg Sci. 2010;17:449-454.
46. Mehrabi A, Mood Z, Roshanaei N, et al. Mesohepatectomy as an option for the treatment of central liver tumors. J Am Coll Surg. 2008;207:499-509.
47. Sotiropoulos GC, LangH, Sotiropoulos GC, et al. Partial or completemesohepatectomy combined with resection of the hilar bifurcation in cases of Klatskin tumors: a reasonable strategy? Am J Surg. 2009;198:297-298.
48. Lise M, Bacchetti S, Da Pian P, et al. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer. 1998;82:1028-1036. (Pubitemid 28136514)
49. Ikai I, Arii S, Kojiro M, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer. 2004;101:796-802. (Pubitemid 39030937)
50. Poon RT, Fan ST, Ng IO, et al. Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg. 2000;231: 544-551. (Pubitemid 30185862)
51. Matsui Y, Terakawa N, Satoi S, et al. Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection. Arch Surg. 2007;142:596-602. (Pubitemid 47080436)
52. Shi M, Guo RP, Lin XJ, et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg. 2007;245:36-43. (Pubitemid 46035433)
53. ShimadaK, SakamotoY, Esaki M, et al.Role of the width of the surgical margin in a hepatectomy for small hepatocellular carcinomas eligible for percutaneous local ablative therapy. Am J Surg. 2008;195:775-781. (Pubitemid 351749464)
54. Jonas S, Thelen A, Benckert C, et al. Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg. 2009;249:303-309.
55. Uenishi T, Yamazaki O, Yamamoto T, et al. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2005;12:479-483. (Pubitemid 43124443)
56. Konstadoulakis MM, Roayaie S, Gomatos IP, et al. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery. 2008;143:366-374.
57. Shimada K, Sano T, Sakamoto Y, et al. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases. J Surg Oncol. 2007;96: 160-165. (Pubitemid 47264820)
58. Paik KY, Jung JC, Heo JS, et al. What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol. 2008;23:766-770. (Pubitemid 351519418)
59. Weber SM, Jarnagin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg. 2001;193: 384-391. (Pubitemid 32895979)
60. Tamandl D, Herberger B, Gruenberger B, et al. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2008;15:2787-2794.
61. FargesO, FuksD. Clinical presentation and management of intrahepatic cholangiocarcinoma. Gastroenterol Clin Biol. 2010;34:191-199.
62. Cho SY, Park SJ, Kim SH, et al. Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol. 2010;17:1823-1830.
63. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644-657.
64. Kemeny NE, Melendez FD, Capanu M, et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2009;27:3465-3471.
65. Masi G, Loupakis F, Pollina L, et al. Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg. 2009;249:420-425.
66. Barone C, Nuzzo G, Cassano A, et al. Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases. Br J Cancer. 2007;97: 1035-1039. (Pubitemid 47587006)
67. Alberts SR, Horvath WL, Sternfeld WC, et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol. 2005;23:9243-9249.
68. Zelek L, Bugat R, Cherqui D, et al. Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial). Ann Oncol. 2003;14:1537-1542. (Pubitemid 37304610)
69. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007-1016. (Pubitemid 351392040)
70. Blazer DG 3rd, Kishi Y, Maru DM, et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008;26:5344-5351.
71. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065-2072. (Pubitemid 46622116)
72. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006;243:1-7. (Pubitemid 43054046)
73. Welsh FK, Tilney HS, Tekkis PP, et al. Safe liver resection following chemotherapy for colorectal metastases is amatter of timing. Br J Cancer. 2007;96:1037-1042. (Pubitemid 46608314)
74. Cho CS, Curran S, Schwartz LH, et al. Preoperative radiographic assessment of hepatic steatosis with histologic correlation. J Am Coll Surg. 2008;206: 480-488. (Pubitemid 351282515)
75. Ward J, Guthrie JA, Sheridan MB, et al. Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases. J Clin Oncol. 2008;26:4304-4310.
76. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg. 2005;200:845-853. (Pubitemid 40744790)
77. Abdalla EK, Adam R, Bilchik AJ, et al. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13:1271-1280. (Pubitemid 44435793)
78. Bodingbauer M, Tamandl D, Schmid K, et al. Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg. 2007;94:1133-1138. (Pubitemid 350082861)
79. DeMatteo RP, Palese C, Jarnagin WR, et al. Anatomic segmental resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg. 2000;4:178-184.
80. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715-722.
81. Hamady ZZ, Cameron IC, Wyatt J, et al. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1 cm rule. Eur J Surg Oncol. 2006;32:557-563.
82. Figueras J, Burdio F, Ramos E, et al. Effect of subcentimeter nonpositive resectionmargin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol. 2007;18:1190-1195. (Pubitemid 47244365)
83. Zorzi D, Mullen JT, Abdalla EK, et al. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg. 2006;10:86-94. (Pubitemid 41820593)
84. Sarpel U, Bonavia AS, Grucela A, et al. Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol. 2009;16:379-384.
85. Finch RJ, Malik HZ, Hamady ZZ, et al. Effect of type of resection on outcome of hepatic resection for colorectal metastases. Br J Surg. 2007;94:1242-1248. (Pubitemid 47584773)
86. de Haas RJ, Wicherts DA, Flores E, et al. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008;248:626-637.
87. Are C, Gonen M, Zazzali K, et al. The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg. 2007;246:295-300. (Pubitemid 47196528)
88. Shirabe K, Takenaka K, Gion T, et al. Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg. 1997;84:1077-1080. (Pubitemid 27359477)
89. Wakai T, Shirai Y, Sakata J, et al. Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis. Ann Surg Oncol. 2008;15:2472-2481.
90. Elias D, Bonnet S, Honoŕe C, et al. Comparison between the minimum margin defined on preoperative imaging and the final surgical margin after hepatectomy for cancer: how to manage it? Ann Surg Oncol. 2008;15:777-781.
91. Torzilli G, Del Fabbro D, Palmisano A, et al. Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases. J Gastrointest Surg. 2005;9:1148-1153.
92. Que FG, Nagorney DM, Batts KP, et al. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg. 1995;169:36-42.
93. Sarmiento JM,Heywood G, Rubin J, et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003;197:29-37. (Pubitemid 36759176)
94. Chamberlain RS, Canes D, Brown KT, et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg. 2000;190: 432-445. (Pubitemid 30181109)
95. Weitz J, Blumgart LH, Fong Y, et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg. 2005;241:269-276.
96. Yedibela S, Gohl J, Graz V, et al. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a singleinstitutional review. Ann Surg Oncol. 2005;12:778-785. (Pubitemid 41355929)
97. Adam R, Chiche L, Aloia T, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg. 2006;244:524-535.
98. Liu CL, Fan ST, Lo CM, et al. Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg. 2000;232:25-31.
99. Liu CL, Fan ST, Cheung ST, et al. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg. 2006;244:194-203. (Pubitemid 44305533)
100. Belghiti J, Guevara OA, Noun R, et al. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg. 2001;193:714-716.
101. Ogata S, Belghiti J, Varma D, et al. Two hundred liver hanging maneuvers for major hepatectomy: a single-center experience. Ann Surg. 2007;245:31-35. (Pubitemid 46035432)
102. Kim SH, Park SJ, Lee SA, et al. Various liver resections using hanging maneuver by three glisson's pedicles and three hepatic veins. Ann Surg. 2007;245:201-205. (Pubitemid 46148478)
103. WoodwardWA,Vinh-HungV, Ueno NT, et al. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol. 2006;24:2910-2916. (Pubitemid 46630594)
104. White RR, Stanley WE, Johnson JL, et al. Long-term survival in 2505 patients with melanoma with regional lymph node metastasis. Ann Surg. 2002;235:879-887. (Pubitemid 34547308)
105. Barbour AP, Rizk NP, Gonen M, et al. Lymphadenectomy for adenocarcinoma of the gastro-esophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol. 2007;14:306-316. (Pubitemid 46175270)
106. Yeo CJ, Cameron JL, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg. 1999;229:613-622.
107. Prandi M, Lionetto R, Bini A, et al. Prognosis of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg. 2002;235:458-463. (Pubitemid 34258343)
108. Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 2nd English edition. Tokyo, Kanehara; 2003 8-9.
109. Yamamoto M, Takasaki K, Yoshikawa T. Lymph node metastasis in intrahepatic cholangiocarcinoma. Jpn J Clin Oncol. 1999;29:147-150.
110. Ercolani G, Grazi GL,RavaioliM, et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg. 2004;239:202-209. (Pubitemid 38176354)
111. Jaeck D, Nakano H, Bachellier P, et al. Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol. 2002;9:430-438. (Pubitemid 34625801)
112. Bennett JJ, Schmidt CR, Klimstra DS, et al. Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal meta stases. Ann Surg Oncol. 2008;15:1130-1136.
113. Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233:385-392. (Pubitemid 32187818)
114. Sun HC, Zhuang PY, Qin LX, et al. Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and routine complete lymphadenectomy. J Surg Oncol. 2007;96:37-45.
115. Xiaohong S, Huikai L, Feng W, et al. Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma. World J Surg. 2010;34:1028-1033.
116. Stipa F, Yoon SS, Liau KH, et al. Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer. 2006;106:1331-1338. (Pubitemid 43363911)
117. Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248:84-96.
118. Shimada M, Yamashita Y, Aishima S, et al. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg. 2001;88:1463-1466. (Pubitemid 32989464)
119. Nakagawa T, Kamiyama T, Kurauchi N, et al. Number of lymph node meta stases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg. 2005;29:728-733.d
120. Nathan H, Aloia TA, Vauthey JN, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009;16:14-22.
121. Yubin L, Chihua F, Zhixiang J, et al. Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China. Ann Surg Oncol. 2008;15:2113-2119.
122. Beckurts KT, Ḧolscher AH, Thorban S, et al. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal livermetastases. Br J Surg. 1997;84:1081-1084. (Pubitemid 27359478)
123. Laurent C, Sa Cunha A, Rullier E, et al. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg. 2004;198:884-891. (Pubitemid 38759838)
124. Minagawa M, Ikai I, MatsuyamaY, et al. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg. 2007;245:909-922. (Pubitemid 46809293)
125. Mazzaferro V, Chun YS, Poon RT, et al. Liver transplantation for hepatocel lular carcinoma. Ann Surg Oncol. 2008;15:1001-1007.
126. Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62-67. (Pubitemid 29023987)
127. Shi J, Lai EC, Li N, et al. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. Ann Surg Oncol. 2010;17:2073-2080.
128. Minagawa M, Makuuchi M, Takayama T, et al. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg. 2001;233:379-384. (Pubitemid 32187817)
129. Hemming AW, Reed AI, Langham MR, et al. Hepatic vein reconstruction for resection of hepatic tumors. Ann Surg. 2002;235:850-858. (Pubitemid 34547304)
130. Hemming AW, Reed AI, Langham MR Jr, et al. Combined resection of the liver and inferior vena cava for hepatic malignancy. Ann Surg. 2004;239: 712-719.
131. Matsuda M, Suzuki T, Kono H, et al. Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins. J Hepatobiliary Pancreat Surg. 2007;14:289-296. (Pubitemid 46863919)
132. Aoki T, Sugawara Y, Imamura H, et al. Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer. J Am Coll Surg. 2004;198:366-372. (Pubitemid 38283727)
133. Azoulay D, Andreani P, Maggi U, et al. Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience. Ann Surg. 2006;244:80-88. (Pubitemid 44297451)
134. Jarnagin WR, GonenM, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397-406.
135. Asahara T, Katayama K, Itamoto T, et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg. 1999;23:676-680. (Pubitemid 29314408)
136. Farid SG, Aldouri A,Morris-Stiff G, et al. Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg. 2010;251:91-100.
137. Hirai T, Yamashita Y, Mukaida H, et al. Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today. 1998;28:576-579. (Pubitemid 28287698)
138. Le T, Alshaikh G, Hopkins L, et al. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking. Ann Surg Oncol. 2006;13:1711-1716. (Pubitemid 44951481)
139. Farges O, Belghiti J, Kianmanesh R, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003;237:208-217. (Pubitemid 38173248)
140. Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364-372. (Pubitemid 43327769)
141. Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 2008; 247:49-57.
142. Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg. 2000;232:665-672.
143. Kawasaki S, Makuuchi M, Kakazu T, et al. Resection for multiple metastatic liver tumors after portal embolization. Surgery. 1994;115:674-677. (Pubitemid 24189760)
144. Jaeck D, Oussoultzoglou E, Rosso E, et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg. 2004;240:1037-1049.
145. Elias D, De Baere T, Roche A, et al. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg. 1999;86:784-788. (Pubitemid 29271944)
146. Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology. 2001;34:267-272. (Pubitemid 32702339)
147. Oussoultzoglou E, Bachellier P, Rosso E, et al. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann Surg. 2006;244:71-79. (Pubitemid 44297450)
148. Mueller L, Hillert C,M̈oller L, et al. Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol. 2008;15:1908-1917.
149. Belghiti J, Benhaïm L. Portal vein occlusion prior to extensive resection in colorectal liver metastasis: a necessity rather than an option! Ann Surg Oncol. 2009;16:1098-1099.
150. Góeŕe D, Farges O, Leporrier J, et al: Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg. 2006;10:365-370. (Pubitemid 43303830)
151. CoveyAM, BrownKT, JarnaginWRet al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for respectable hepatic colorectal metastases. Ann Surg. 2008;247:451-455.
152. Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg. 2004;240:1052-1061.
153. Belghiti J, Noun R, Malafosse R, et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg. 1999;229: 369-375. (Pubitemid 30191772)
154. Man K, Fan ST, Ng IO, et al. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg. 1997;226: 704-711.
155. Clavien PA, Selzner M, R̈udiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003;238:843-850.
156. Chouk̀er A, Schachtner T, Schauer R, et al. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth. 2004;93: 204-211. (Pubitemid 39117395)
157. Azoulay D, Lucidi V, Andreani P, et al. Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. J Am Coll Surg. 2006;202:203-211. (Pubitemid 43112477)
158. Petrowsky H, McCormack L, Trujillo M, et al. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg. 2006;244:921-928. (Pubitemid 44808626)
159. Gurusamy KS, Kumar Y, Pamecha V, et al. Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion. Cochrane Database Syst Rev. 2009;(1):CD007629.
160. Domart MC, Esposti DD, Sebagh M, et al. Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy. J Hepatol. 2009;51:881-889.
161. Smyrniotis V, Theodoraki K, Arkadopoulos N, et al. Ischemic preconditioning versus intermittent vascular occlusion in liver resections performed under selective vascular exclusion: a prospective randomized study. Am J Surg. 2006;192:669-674. (Pubitemid 44634326)
162. NijkampMW, van der Bilt JD, Snoeren N et al. Prolonged portal triad clamping during liver surgery for colorectal liver metastases is associated with decreased time to hepatic tumour recurrence. Eur J Surg Oncol. 2010;36: 182-188.
163. Capussotti L, Muratore A, Ferrero A, et al. Randomized clinical trial of liver resection with and without hepatic pedicle clamping. Br J Surg. 2006;93: 685-689. (Pubitemid 43886019)
164. Belghiti J, Scatton O, Varma D. Vascular isolation techniques in liver resection in Blumgart LH (ed): Surgery of the Liver, Biliary Tract and Pancreas. Philadelphia, PA: Saunders Elsevier; 2007:1417-1426.
165. Belghiti J, Noun R, Zante E, et al. Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg. 1996;224: 155-161. (Pubitemid 26272061)
166. Varma D, Ogata S, Belghiti J. Isolated total caval clamping with 'preserved remnant liver perfusion' for combined hepatic and venacaval resection in tumors involving vena cava. Surgery. 2007;141:112-116. (Pubitemid 44918071)
167. Scatton O, Plasse M, Dondero F, et al. Impact of localized congestion related to venous deprivation after hepatectomy. Surgery. 2008;143:483-489.
168. Buell JF, Cherqui D, Geller DA, et al. World Consensus Conference on Laparoscopic Surgery. The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg. 2009;250:825-830.
169. Bryant R, Laurent A, Tayar C, et al. Laparoscopic liver resectionunderstanding its role in current practice: the Henri Mondor Hospital experience. Ann Surg 2009; 250:103-111.
170. Blumgart LH, Hann LE. Surgical and radiologic anatomy of the liver, biliary tract, and pancreas. In: Blumgart LH ed. Surgery of the Liver, Biliary Tract and Pancreas. Philadelphia, PA: Saunders Elsevier; 2007:3-29.